Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma
1998

Prognostic Significance of Methyl-p-Hydroxyphenyllactate-Esterase Activity in Laryngeal Cancer

Sample size: 63 publication Evidence: moderate

Author Information

Author(s): M Maurizi, G Ferrandina, G Almadori, G Scambia, G Cadoni, G D'Agostino, FG Serra, M Piantelli, S Mancuso, FO Ranelletti

Primary Institution: Catholic University, Rome

Hypothesis

Does methyl-p-hydroxyphenyllactate esterase activity correlate with clinical outcomes in laryngeal squamous cell carcinoma?

Conclusion

High levels of methyl-p-hydroxyphenyllactate esterase activity are associated with better overall and relapse-free survival in laryngeal cancer patients.

Supporting Evidence

  • 49% of patients experienced locoregional recurrences during the follow-up period.
  • 43% of patients died of cancer by the end of the study.
  • Cox univariate analysis showed that higher MeHPLAase activity was inversely associated with the risk of death and relapse.

Takeaway

This study found that patients with higher levels of a specific enzyme in their laryngeal cancer had a better chance of surviving and not having their cancer come back.

Methodology

The study analyzed methyl-p-hydroxyphenyllactate esterase activity in tumor samples from 63 untreated primary laryngeal squamous cell carcinoma patients and correlated it with clinical outcomes.

Limitations

The study was conducted at a single institution and may not be generalizable to all populations.

Participant Demographics

The study included 63 untreated consecutive primary laryngeal SCC patients, with a median follow-up of 50 months.

Statistical Information

P-Value

0.0124

Confidence Interval

60-97%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication